Trade Opportunity
Export Pharmaceuticals from Belgium to Latvia under the EU-Mercosur Agreement 2026. Reduced tariffs and preferential access to a market of 780 million consumers.
📌 Why This Matters
Small and medium enterprises stand to gain significantly from reduced barriers.
💰 Cost Savings: Average tariff reduction of 35% on industrial goods.
🔗 Related Opportunities
📌 Why This Matters
With 780 million consumers, this market offers unprecedented opportunities.
🌍 Market Access: Direct access to 780 million consumers across 31 countries.